Ofev — Medica

Initial criteria

• Patient is ≥ 18 years of age
• Diagnosis is confirmed by high-resolution computed tomography
• Medication is prescribed by or in consultation with a pulmonologist

Reauthorization criteria

• Patient is ≥ 18 years of age
• Patient has experienced a beneficial response to therapy over the last year while receiving Ofev (examples include a reduction in the anticipated decline in forced vital capacity, six-minute walk distance, and/or in the number or severity of interstitial lung disease-related exacerbations)
• Medication is prescribed by or in consultation with a pulmonologist

Approval duration

1 year